When we talk about risk management in clinical trial supply, we’re usually referring to two types of risk: the risk that patients will miss dispensing and the risk of global drug shortage.
There are two types of clinical trial supply risk management plans: proactive and reactive.read more
With pharma and biotechs’ ambitions to do more with less, the supply chain quickly becomes the center of attention in the attempt to supply trials faster, more efficiently, and with lower waste levels.
Discover how some often overlooked parameters can have a significant impact on IMP waste and supply risk.watch on demand
They are many factors that contribute to bottlenecks in the supply chain, including the increasing complexity of clinical trial designs, the shorter products shelf lives in innovative treatments, a severe shortage of manufacturing resources, etc.
See what clinical supply chain managers can do to curb these risks.read more